Strategies for overcoming anti-tumor necrosis factor drug antibodies in inflammatory bowel disease: Case series and review of literature

Table 1 Management of secondary loss of response

	No/low antibody level	High antibody level
Low drug level	Increase drug dose	Change therapy (within class or alternate class)
Normal/high drug level	Change therapy (alternate class)	(Not clinically relevant scenario)